BSX vs. UHS: Boston Scientific vs. Universal Health Services Stock Comparison

Company Profile

Boston Scientific (BSX) and Universal Health Services (UHS) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while UHS is classified in Health Care Providers & Services.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Boston Scientific (BSX) is heavily traded at around 19.73M shares per day, whereas Universal Health Services (UHS) sees a more moderate 707.83K — larger orders in the latter may require more patience and tighter control over order sizing.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Universal Health Services (UHS) at 19.74% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for UHS.

Boston Scientific (BSX) at 16.62% retains a top-quartile share of revenue as profit, ahead of Universal Health Services (UHS) at 7.97%, which keeps about the industry-typical share.

Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of Universal Health Services (UHS) at 9.60%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both Boston Scientific (BSX) at 19.87% and Universal Health Services (UHS) at 9.71% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both Boston Scientific (BSX) at 55.20% and Universal Health Services (UHS) at 37.34% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.

Growth Metrics

Financial Strength

Universal Health Services (UHS) at 1.37 keeps current ratio within its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BSX.

Both Boston Scientific (BSX) at 0.46 and Universal Health Services (UHS) at 0.80 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Universal Health Services (UHS) reports a yield of 0.10%, ranking against industry peers normally.

Boston Scientific (BSX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Universal Health Services (UHS) reports a payout of 3.35%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Boston Scientific (BSX) at 18.04 and Universal Health Services (UHS) at 8.18 sit in the cheaper earnings-multiple quartile for P/E ratio, with the market paying less for a dollar of trailing earnings than it pays for typical peers.

Universal Health Services (UHS) at 0.63 sits in the cheaper P/S ratio quartile while Boston Scientific (BSX) at 2.94 prices around its industry’s middle — UHS costs less per dollar of sales, though read it alongside growth and margins.

Universal Health Services (UHS) at 1.51 sits in the lower P/B ratio quartile against book while Boston Scientific (BSX) at 2.42 is valued near its industry’s middle — UHS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics